DYAI

Conviction 67HealthcareScan · Mon, Aug 10, 2026

DYAI$0.9745-2.55%

ResistanceSupportVol 14

Vol MA14 172.85K

May 11May 28Jun 16Jul 6Jul 23Aug 10

DYADIC INTERNATIONAL INCBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)www.dyadic.com ↗

Price0.9745

Change-2.55%

Gap+1.00%

Rel volume0.10×

Avg volume223.42K

Avg $ vol266.51K

SMA 201.14

SMA 500.9518

SMA 2000.8939

Price vs 50+2.38%

Price vs 200+9.01%

MA stackbullish

50/200 crossgolden · 9d

Supertrendup · 0.9402

RSI (14)45

MACD hist-0.03

MACD cross—

Stoch %K / %D4 / 7

ADX (14)47

+DI / −DI20 / 11

RSI divergence—

MACD divergence—

ATR %+12.99%

ADR %13.11%

52w high1.47

52w low0.6754

From 52w high-33.71%

Above 52w low+44.28%

New 52w highNo

SqueezeOff

Bollinger width43.18%

%B0.17

Donchian pos3.77%

Donchian high1.60

Donchian low0.9500

AVWAP (52w high)1.14

vs AVWAP high-14.86%

AVWAP (52w low)0.8583

vs AVWAP low+13.54%

OBV trendFlat

Chaikin MF (20)-0.25

Today vs 20d0.10×

Avg vol (14d)172.85K

Avg vol (20d)223.42K

Avg $ vol (20d)266.51K

Market cap—

RS 3m (vs SPY)+28.53%

RS 6m (vs SPY)+3.60%

RS line new highNo

Trend template5/8

Technical rank59.4

1 week-8.07%

1 month-8.07%

3 months+27.14%

6 months+14.42%

1 year+2.59%

YTD+3.68%

P/E-5.00

P/B-90.26

P/S11.91

P/FCF—

EPS-0.2300

Div yield—

ROE—

ROA-94.30%

Debt/Eq—

Current2.42

EV/EBITDA—

Gross margin—

Net margin-238.31%

Rev growth-11.59%

EPS growth-26.78%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value32.56M

Revenue1.11M

Net income-1.95M

Gross profit—

Free cash flow—

IndustryBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)

ExchangeNasdaq

Shares out36.44M

Employees5

ListedFri, Nov 5, 2004

Free float—

Float %—

Short interest—

Days to cover—

Short volume—

Squeeze score—

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeB

Conviction67 / 100

Pattern quality—

Tech rank59.4 / 100

Group rank86 / 100 · Leading

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.47

Support0.8400

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Mar 31, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in DYAI

All disclosures →

No recent disclosed trades by Congress in DYAI. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in DYAI

No recent insider (Form 4) filings in DYAI. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in DYAI · 7 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.